Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review focuses …

… and treatment of venous thromboembolism in patients with cancer. These drugs … patients
with more favourable outlook. About 10% of patients with idiopathic venous thromboembolism …

… The association between venous thromboembolism (VTE) and cancer … Patients with cancer
are at 4- to 7-fold higher risk for VTE than patients without cancer, and about 15% of patients …

Background People with cancer are known to be at increased risk of venous thromboembolism
(VTE), and this risk is believed to vary according to cancer type, stage of disease, and …

… cancer who did or did not develop venous thromboembolism … of venous thromboembolism
among breast cancer patients who … of local stage breast cancer versus a matched sample of …

… of VTE in the cancer patient is its effect on mortality. Death in cancer patients with VTE
can be directly attributable to the thromboembolic event itself; just as importantly, cancer …

… Cancer and its treatments are well-recognized risk factors for venous thromboembolism (VTE).
Although the incidence of VTE in cancer patients is not well documented, there is …

… risk in patients with hematological cancers.5, 6 However, cancers … venous thromboembolism.5,
6 A review of cancer patients who … deep venous thrombosis as noncancer patients who …

… in all patients presenting with idiopathic venous thromboembolism, … in patients with cancer.
©1999, Ferrata Storti Foundation … for occult cancer in patients with venous thromboembolism. …

… initial therapy for cancer patients with central venous catheter–associated DVT, calf … Venous
thromboembolism (VTE) is a common cause of morbidity and mortality in patients with cancer…